Cargando…

Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature

BACKGROUND: Gallbladder cancer is a rare type of malignancy with overall poor prognosis. It represents the most common type of biliary tract cancer. Surgical resection can provide cure for those presenting in early stages. However, patients presenting with locally advanced or metastatic disease are...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Jaber, Fatimah, Almaher, Eman, Al-Ibrahim, Rawan, AlQahtani, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574416/
https://www.ncbi.nlm.nih.gov/pubmed/36242892
http://dx.doi.org/10.1016/j.ijscr.2022.107694
_version_ 1784811101027827712
author Al Jaber, Fatimah
Almaher, Eman
Al-Ibrahim, Rawan
AlQahtani, Mohammed
author_facet Al Jaber, Fatimah
Almaher, Eman
Al-Ibrahim, Rawan
AlQahtani, Mohammed
author_sort Al Jaber, Fatimah
collection PubMed
description BACKGROUND: Gallbladder cancer is a rare type of malignancy with overall poor prognosis. It represents the most common type of biliary tract cancer. Surgical resection can provide cure for those presenting in early stages. However, patients presenting with locally advanced or metastatic disease are considered unresectable and the first line of management in such cases is chemotherapy. CASE PRESENTATION: 60 years old Saudi female with no previous medical background who was diagnosed at local hospital to have unresectable metastatic gallbladder cancer to the liver. She received 6 cycles of neoadjuvant chemotherapy as the standard protocol (Gemcitabin + Cisplatin). She showed a good response and after a multidisciplinary tumor board decision was then taken for a successful curative surgical resection (R0). Post operatively, she had another 4 cycles adjuvant chemotherapy of the same regimen. She is still on active surveillance, alive in a good condition with no local recurrence or distant metastasis after 42 months post operatively. DISCUSSION: Patients with gallbladder cancer are often diagnosed at late stages and those with locally advanced or metastatic gallbladder cancer are not candidates for surgical resection, even though it is a principal part of management to achieve cure. A conversion surgical resection is yet possible in selected patients initially labeled as having unresectable gallbladder cancer following neoadjuvant chemotherapy. CONCLUSION: A conversion surgical resection can achieve cure in appropriately selected candidates initially labeled as unresectable gallbladder cancer following good response to neoadjuvant chemotherapy. Careful patient selection and multidisciplinary team management is recommended. Further studies are needed to standardized the management approach regarding criteria for eligible candidates, timing before considering conversion, and extent of resection.
format Online
Article
Text
id pubmed-9574416
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95744162022-10-18 Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature Al Jaber, Fatimah Almaher, Eman Al-Ibrahim, Rawan AlQahtani, Mohammed Int J Surg Case Rep Case Report BACKGROUND: Gallbladder cancer is a rare type of malignancy with overall poor prognosis. It represents the most common type of biliary tract cancer. Surgical resection can provide cure for those presenting in early stages. However, patients presenting with locally advanced or metastatic disease are considered unresectable and the first line of management in such cases is chemotherapy. CASE PRESENTATION: 60 years old Saudi female with no previous medical background who was diagnosed at local hospital to have unresectable metastatic gallbladder cancer to the liver. She received 6 cycles of neoadjuvant chemotherapy as the standard protocol (Gemcitabin + Cisplatin). She showed a good response and after a multidisciplinary tumor board decision was then taken for a successful curative surgical resection (R0). Post operatively, she had another 4 cycles adjuvant chemotherapy of the same regimen. She is still on active surveillance, alive in a good condition with no local recurrence or distant metastasis after 42 months post operatively. DISCUSSION: Patients with gallbladder cancer are often diagnosed at late stages and those with locally advanced or metastatic gallbladder cancer are not candidates for surgical resection, even though it is a principal part of management to achieve cure. A conversion surgical resection is yet possible in selected patients initially labeled as having unresectable gallbladder cancer following neoadjuvant chemotherapy. CONCLUSION: A conversion surgical resection can achieve cure in appropriately selected candidates initially labeled as unresectable gallbladder cancer following good response to neoadjuvant chemotherapy. Careful patient selection and multidisciplinary team management is recommended. Further studies are needed to standardized the management approach regarding criteria for eligible candidates, timing before considering conversion, and extent of resection. Elsevier 2022-09-21 /pmc/articles/PMC9574416/ /pubmed/36242892 http://dx.doi.org/10.1016/j.ijscr.2022.107694 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Al Jaber, Fatimah
Almaher, Eman
Al-Ibrahim, Rawan
AlQahtani, Mohammed
Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature
title Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature
title_full Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature
title_fullStr Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature
title_full_unstemmed Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature
title_short Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: Case report and review of literature
title_sort curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: case report and review of literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574416/
https://www.ncbi.nlm.nih.gov/pubmed/36242892
http://dx.doi.org/10.1016/j.ijscr.2022.107694
work_keys_str_mv AT aljaberfatimah curativesurgicalresectionforinitiallyunresectablemetastaticgallbladdercancerfollowingneoadjuvantchemotherapycasereportandreviewofliterature
AT almahereman curativesurgicalresectionforinitiallyunresectablemetastaticgallbladdercancerfollowingneoadjuvantchemotherapycasereportandreviewofliterature
AT alibrahimrawan curativesurgicalresectionforinitiallyunresectablemetastaticgallbladdercancerfollowingneoadjuvantchemotherapycasereportandreviewofliterature
AT alqahtanimohammed curativesurgicalresectionforinitiallyunresectablemetastaticgallbladdercancerfollowingneoadjuvantchemotherapycasereportandreviewofliterature